NKGen Financial Statements From 2010 to 2025
| NKGN Stock | 0.05 0 1.96% |
Check NKGen Biotech, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NKGen Biotech,'s main balance sheet or income statement drivers, such as , as well as many indicators such as . NKGen financial statements analysis is a perfect complement when working with NKGen Biotech, Valuation or Volatility modules.
NKGen |
NKGen Biotech, Common Company Return On Asset Analysis
NKGen Biotech,'s Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current NKGen Biotech, Return On Asset | -1.07 |
Most of NKGen Biotech,'s fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NKGen Biotech, Common is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, NKGen Biotech, Common has a Return On Asset of -1.0685. This is 87.79% lower than that of the Biotechnology sector and 95.47% lower than that of the Health Care industry. The return on asset for all United States stocks is notably higher than that of the company.
NKGen Biotech, Common Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NKGen Biotech,'s current stock value. Our valuation model uses many indicators to compare NKGen Biotech, value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NKGen Biotech, competition to find correlations between indicators driving NKGen Biotech,'s intrinsic value. More Info.NKGen Biotech, Common is rated below average in return on asset category among its peers. It is rated top company in current valuation category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value NKGen Biotech, by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NKGen Biotech,'s Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About NKGen Biotech, Financial Statements
NKGen Biotech, investors utilize fundamental indicators, such as revenue or net income, to predict how NKGen Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Pair Trading with NKGen Biotech,
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NKGen Biotech, position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NKGen Biotech, will appreciate offsetting losses from the drop in the long position's value.Moving against NKGen Pink Sheet
| 0.79 | SMGKF | Smiths Group plc | PairCorr |
| 0.62 | STAG | STAG Industrial | PairCorr |
| 0.56 | ARRXF | Archer Materials | PairCorr |
| 0.39 | BCAB | Bioatla | PairCorr |
| 0.36 | SHG | Shinhan Financial | PairCorr |
The ability to find closely correlated positions to NKGen Biotech, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NKGen Biotech, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NKGen Biotech, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NKGen Biotech, Common to buy it.
The correlation of NKGen Biotech, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NKGen Biotech, moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NKGen Biotech, Common moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NKGen Biotech, can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in NKGen Pink Sheet
NKGen Biotech, financial ratios help investors to determine whether NKGen Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in NKGen with respect to the benefits of owning NKGen Biotech, security.